Menu Search
Equities

Spyre Therapeutics Inc

3920:BER

Spyre Therapeutics Inc

Actions
  • Price (EUR)33.90
  • Today's Change-3.60 / -9.60%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 20:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Spyre Therapeutics Inc increased its cash reserves by 419.59%, or 152.80m. Cash Flow from Financing totalled 361.08m or 40,753.61% of revenues. In addition the company used 99.91m for operations while cash used for investing totalled 108.39m.
Cash flow per share-5.79
Price/Cash flow per share--
Book value per share6.37
Tangible book value per share6.37
More ▼

Balance sheet in USDView more

Spyre Therapeutics Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 188.89m.
Current ratio7.32
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.